eTheRNA immunotherapies is developing first in class mRNA immunotherapies for the treatment of cancer and infectious diseases.
Location: Belgium, Antwerp, Niel
Employees: 51-200
Total raised: $38.86M
Founded date: 2013
Investors 3
| Date | Name | Website |
| - | Omega Fund... | omegafunds... |
| - | Fund+ | fundplus.b... |
| - | Life Scien... | lspvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.08.2022 | - | $38.86M | - |
Mentions in press and media 8
| Date | Title | Description | Source |
| 27.08.2022 | eTheRNA Raises €39M in Series B2 Financing | eTheRNA, a Niel, Belgium-based mRNA technologies company, raised €39M in a Series B2 financing. The ... | finsmes.co... |
| 03.02.2022 | eTheRNA immunotherapies and Ghent University Announce mRNA D... | Partnership Press Release | fundplus.b... |
| 18.01.2022 | 4basebio Plc - Strategic Research Collaboration | 18 January 2022 4basebio PLC ("4basebio", the "Company" or the “Group”) Strategi... | marketscre... |
| 16.06.2020 | ETheRNA nabs €34M for mRNA vaccines—including COVID-19 candi... | Belgium’s eTheRNA picked up €34 million ($38 million) to bankroll the development of its mRNA techno... | fiercebiot... |
| 16.06.2020 | eTheRNA Raises EUR 34 Million in Series B Financing to Accel... | - | novalislif... |
| 16.06.2020 | eTheRNA : Raises EUR 34 Million in Series B Financing to Acc... | NIEL, Belgium, June 16, 2020 /PRNewswire/ -- eTheRNA immunotherapies NV ('eTheRNA' or 'The Company')... | marketscre... |
| 16.06.2020 | eTheRNA Raises €34M in Series B Financing | eTheRNA immunotherapies, a Niel, Belgium-based clinical-stage company developing immunotherapies fro... | finsmes.co... |
| 15.06.2020 | ETheRNA nabs €34M for mRNA vaccines—including COVID-19 candi... | Belgium’s eTheRNA picked up €34 million ($38 million) to bankroll the development of its mRNA techno... | fiercebiot... |